BCL2 and ischemic stroke: Furthermore, it was shown that rTMS ameliorates cognitive deficits, lesion size via the activation of Bcl-2, and inhibition of Bax and cytochrome-c release and inflammation after ischemic stroke post-hemi-cerebellectomy in rats.